Showing results (431-440 of 555) with videos related to
Sort By:
Pageof 56
Journal of Neural Transmission. Supplementum|January 1, 1994
Interactions of neurotoxins with non-NMDA glutamate receptors: an autoradiographic studyG Künig, B Niedermeyer, F Krause, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neuronsG Bringmann, R God, D Feineis, et al.Journal of Neurovirology|June 19, 2004
Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeysM Jenuwein, C Scheller, E Neuen-Jacob, et al.Toxicology and Applied Pharmacology|October 17, 1998
Scavestrogens protect IMR 32 cells from oxidative stress-induced cell deathD Blum-Degen, M Haas, S Pohli, et al.Brain & Development|January 1, 1985
Neurochemical aspects of the Rett syndromeP Riederer, T Brücke, E Sofic, et al.Pharmacopsychiatry|July 25, 2008
The influence of smoking on the serum level of duloxetineM Fric, B Pfuhlmann, G Laux, et al.Neuroscience Letters|December 21, 2000
The human dopamine transporter gene: the 5'-flanking region reveals five diallelic polymorphic sites in a Caucasian population sampleC Rubie, F Schmidt, M Knapp, et al.Neuroreport|June 2, 1994
Memantine inhibits [3H]MK-801 binding to human hippocampal NMDA receptorsW Berger, J Deckert, J Hartmann, et al.Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.Journal of Neural Transmission|January 1, 1989
[3H]MK-801 binding sites in postmortem brain regions of schizophrenic patientsJ Kornhuber, F Mack-Burkhardt, P Riederer, et al.Pageof 56